A new robust methodology
for gram-scale iron-catalyzed cross-coupling
between alkyl Grignard reagents and alkenyl or aryl halides is developed.
This method does not require toxic additives such as NMP or expensive
ligands. Its efficiency relies on the use of simple alkoxide magnesium
salts as additives. On the basis of these results, a new procedure
for one-pot synthesis of substituted benzamides from chloroesters
is also proposed.
In the context of cross-coupling chemistry, the competition between the cross-coupling path itself and the oxidative homocoupling of the nucleophile is a classic issue. In that case, the electrophilic partner acts as a sacrificial oxidant. We investigate in this report the factors governing the crossversus homocoupling distribution using aryl nucleophiles ArMgBr and (hetero)aryl electrophiles Ar′Cl in the presence of an iron catalyst. When electron-deficient electrophiles are used, a key transient heteroleptic [Ar 2 Ar′Fe II ] − complex is formed. DFT calculations show that an asynchronous two-electron reductive elimination follows, which governs the selective evolution of the system toward either a cross-or homocoupling product. Proficiency of the cross-coupling reductive elimination strongly depends on both π-accepting and σ-donating effects of the Fe II -ligated Ar′ ring. The reactivity trends discussed in this article rely on two-electron elementary steps, which are in contrast with the usually described tendencies in iron-mediated oxidative homocouplings which involve single-electron transfers. The results are probed by paramagnetic 1 H NMR spectroscopy, experimental kinetics data, and DFT calculations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.